Buy Olmecip H 40 mg (Olmesartan 40 mg + Hydrochlorothiazide 12.5 mg) – Effective Dual Therapy for Hypertension

Olmecip H 40 mg combines olmesartan medoxomil (an angiotensin II receptor blocker) 40 mg with hydrochlorothiazide 12.5 mg (a thiazide diuretic) in one once-daily tablet by Cipla. It’s indicated for adults whose blood pressure is not controlled by a single agent alone. 

How It Works

• Olmesartan relaxes blood vessels by blocking angiotensin II receptors, reducing vascular resistance and lowering blood pressure.
• Hydrochlorothiazide increases fluid and sodium excretion—reducing blood volume and supporting blood pressure control. 

Indications & Benefits

• Indicated for essential hypertension when monotherapy is inadequate. 
• Showing superior BP reduction compared to either component alone—may reduce stroke and heart attack risk over long term.
• Once-daily fixed-dose improves adherence in patients requiring dual therapy. 

Dosage & Administration

• Start with Olmecip H 40 mg (40/12.5 mg) once daily, preferably in the morning, with or without food. Do not crush or chew. 
• If blood pressure isn’t controlled, dose may be increased to 40 mg/25 mg per physician guidance. 
• It may take up to 4 weeks to see the full antihypertensive effect. 

Side Effects & Safety

• Common: dizziness, headache, increased urination, nausea, weakness, swelling of legs, dry mouth, rash. 
• Serious: electrolyte imbalances (low potassium, sodium), kidney impairment, dehydration, gout, skin sensitivity to sun due to HCTZ. 
• Rare: severe allergic reaction, muscle pain or weakness—seek urgent help if observed. 

Precautions & Interactions

• Contraindicated in pregnancy (especially second/third trimesters due to fetal toxicity) and in patients with anuria or hypersensitivity to components. 
• Avoid co‑administration with aliskiren in patients with diabetes or kidney impairment.
• Monitor renal function and electrolytes periodically—especially in renal artery stenosis, dehydration, or heart failure. 
• Avoid salt substitutes containing potassium or potassium-sparing diuretics. NSAIDs may reduce effect and elevate kidney risk.
• Avoid alcohol—it may worsen dizziness or hypotension.

Global Availability & Prescription Info

Olmecip H 40 mg is available only with prescription. Manufactured by Cipla in India and available worldwide via licensed pharmacies with discreet shipping. Medical supervision and regular follow-up are essential. 

📌 Frequently Asked Questions (FAQs)

1. What is Olmecip H 40 mg used for?

It treats hypertension in patients needing dual therapy when a single agent is insufficient. It combines an ARB and diuretic for enhanced efficacy. 

2. How should I take it?

Take one tablet in the morning with or without food. Swallow whole. If a dose is missed and it’s close to next schedule, skip it—don’t double dose. 

3. What side effects should I expect?

Common: tiredness, dizziness, frequent urination. Rare but serious: low sodium/potassium, kidney issues, skin sensitivity, gout flare-ups. See doctor if persisting.

4. Who should avoid Olmecip H?

Not recommended for pregnant/nursing women, patients with no urine output, severe kidney or liver disease, or those allergic to sulfonamide-type drugs.  

5. Can I take it with other BP medications?

Yes, under supervision. Avoid combining with aliskiren in diabetics or kidney disease. Inform your doctor of all medications as diuretics or NSAIDs can interact.